145 results on '"Sprowl, Jason A"'
Search Results
2. SLCO1B1 Pharmacogenetics in Pediatrics
3. Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?
4. A phosphotyrosine switch regulates organic cation transporters.
5. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice
6. OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
7. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake
8. Data from Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
9. Table S2 from Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
10. Supplementary Figure 1 from Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
11. Figure S2 from Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
12. Supplementary Figure 3 from Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
13. Supplementary Figure Legends 1-4 from Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
14. Supplementary Figure 4 from Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
15. Supplementary Table 1 from CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
16. Supplementary Figure 1 from Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
17. Supplementary Figure 2 from Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
18. Supplementary Figure 2 from Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
19. Supplementary Table 1 from Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
20. Supplementary Figure 1 from CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
21. Supplementary Figure Legends from Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
22. Supplementary Figure 3 from Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
23. Comparison of P‐glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients
24. Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
25. Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4
26. Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium
27. Polymorphic Transporters and Platinum Pharmacodynamics
28. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
29. Comparison of P‐glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients.
30. Contribution of tumoral and host solute carriers to clinical drug response
31. Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss
32. Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
33. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice
34. Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity
35. Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity
36. Role of transporters and S100A8/A9 in paclitaxel‐induced peripheral neuropathy
37. Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
38. Genetic and Pharmacological Inhibition of OCT2 Protects Rats against Oxaliplatin‐Induced Peripheral Neuropathy
39. Characterization of OATP1B1 and OATP1B3 inhibition by Nilotinib
40. OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
41. Strategies to Reduce Solute Carrier-Mediated Toxicity
42. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake
43. Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
44. Abstract 5471: Identification of OAT1/OAT3 as contributors to cisplatin nephrotoxicity
45. Abstract 4415: Tyrosine phosphorylation is essential for OCT2 function and a target of inhibition by TKIs
46. Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity
47. Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
48. CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
49. CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity.
50. Uptake Carriers and Oncology Drug Safety
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.